Does ROSUVASTATIN Cause Interstitial lung disease? 268 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 268 reports of Interstitial lung disease have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.7% of all adverse event reports for ROSUVASTATIN.
268
Reports of Interstitial lung disease with ROSUVASTATIN
0.7%
of all ROSUVASTATIN reports
29
Deaths
176
Hospitalizations
How Dangerous Is Interstitial lung disease From ROSUVASTATIN?
Of the 268 reports, 29 (10.8%) resulted in death, 176 (65.7%) required hospitalization, and 22 (8.2%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for ROSUVASTATIN.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which ROSUVASTATIN Alternatives Have Lower Interstitial lung disease Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN